Novus Scientific receives CE Mark Approval for TIGR® Matrix Surgical Mesh - the World’s First Long-Term Resorbable Synthetic Mesh.

Dokument -

Novus Scientific receives CE Mark Approval for TIGR® Matrix Surgical Mesh - the World’s First Long-Term Resorbable Synthetic Mesh.

Singapore /PRNewswire/ — Novus Scientific Pte. Ltd announced today that it has received CE Mark approval for TIGR® Matrix Surgical Mesh, the world’s first long-term resorbable synthetic mesh. TIGR® Matrix is indicated for reinforcement of soft tissue where weakness exists.
  • Licens: All rights reserved
    Innehållet får bara användas av Mynewsdesk. Det är alltså inte tillåtet för någon annan att ladda ner, kopiera, sprida eller på annat sätt använda Innehållet (annat än för privat bruk i den mån det följer av lag).
  • Filformat: .pdf

Kontakter

Jan Hermansson

Presskontakt Global Produktchef Försäljning och Distributörsstöd

Relaterat innehåll

Novus Scientific receives CE Mark Approval for TIGR® Matrix Surgical Mesh - the World’s First Long-Term Resorbable Synthetic Mesh.

Singapore /PRNewswire/ — Novus Scientific Pte. Ltd announced today that it has received CE Mark approval for TIGR® Matrix Surgical Mesh, the world’s first long-term resorbable synthetic mesh. TIGR® Matrix is indicated for reinforcement of soft tissue where weakness exists.